Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03238755 · ClinicalTrials.gov registry record
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study
A clinical trial of HIV Infections, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 129
- Enrollment target
- 4
- Study locations
NCT03238755: Active study of HIV Infections, sponsored by Massachusetts General Hospital.
NCT03238755 is a study of HIV Infections that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 129 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (71% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03238755, a study of HIV Infections, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 129 participants
- Enrollment target
- 4
- Study locations
Study Summary
In this study, investigators plan to test whether statins can preserve and/or improve diastolic function among asymptomatic persons with HIV who are on anti-retroviral therapy. Both myocardial fibrosis and myocardial steatosis are thought to contribute to diastolic dysfunction and eventually overt heart failure in HIV. HIV-positive participants will undergo cardiac MRI/MRS imaging studies for the evaluation of myocardial fibrosis and myocardial steatosis prior to initiation of statin or placebo therapy and then two years after initiation of statin or placebo therapy. Traditional markers of cardiovascular (CVD) risk, systemic immune activation/ inflammation, HIV-specific parameters (i.e. CD4 count), and markers of myocardial stretch/injury will be assessed in relation to cardiac MRI/MRS outcomes.
Conditions Studied
Interventions
- OTHER Cardiac MRI/MRS
Study Locations (4)
California
- VA Medical Center-Los Angeles - Los Angeles
Massachusetts
- Massachusetts General Hospital - Boston
Texas
- UTSW Medical Center - Dallas
Other
- University of Cape Town - Cape Town
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2017-07-31 |
| Est. Completion | 2026-04-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03238755
The ClinicalTrials.gov registry entry for NCT03238755 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (71% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Cardiac MRI/MRS is the first listed.
NCT03238755 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Massachusetts, Texas.
Frequently Asked Questions
What is clinical trial NCT03238755 about?
NCT03238755 is a clinical study titled "Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study". In this study, investigators plan to test whether statins can preserve and/or improve diastolic function among asymptomatic persons with HIV who are on anti-retroviral therapy. Both myocardial fibrosis and myocardial steatosis are thought to contribute to diastolic dysfunction and eventually overt h...
What is the current status of trial NCT03238755?
This trial is currently active not recruiting. The enrollment target is 129 participants. The study started on 2017-07-31. Estimated completion is 2026-04-23.
What conditions does trial NCT03238755 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT03238755?
The interventions under investigation include: Cardiac MRI/MRS (OTHER).
Who is sponsoring clinical trial NCT03238755?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03238755 being conducted?
This trial has 4 study locations across California, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.